In vitro growth in acute myeloblastic leukemia: Clinico-biological correlations

Leukemia and Lymphoma

Volumn 36, Issue 1-2, 1999, Pages 1-7

  Del Cañizo, Consuelo ^a   Galende, Josefina ^a   Almeida, Julia ^a   Brufau, Ana ^a   Mota, Alexandra ^a   San Miguel, J Fernando ^a  

^a HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

Author keywords

Autonomous growth; Clinico biological characteristics; Leukaemic colony units (L CFU); Prognosis

Indexed keywords

CD34 ANTIGEN; GROWTH FACTOR; MEMBRANE ANTIGEN; MULTIDRUG RESISTANCE PROTEIN;

ACUTE MYELOBLASTIC LEUKEMIA; ANTIGEN EXPRESSION; BLAST CELL; CANCER RECURRENCE; CELL FRACTIONATION; CELL GROWTH; CELL MATURATION; CELL POPULATION; CELL PROLIFERATION; CLONOGENIC ASSAY; COLONY FORMING CELL; COLONY FORMING UNIT; COLONY FORMING UNIT GM; CONTROLLED STUDY; HEMATOPOIESIS; HUMAN; HUMAN CELL; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; RELAPSE; REVIEW; STEM CELL; SURVIVAL TIME;

EID: 0033429206     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199909145943     Document Type: Review

References (35)

1. Rusell NH, Autocrine growth factors and leukaemic haemopoiesis. Blood Rev (1992) 6: 159.
2. Buick R, Till JE, McCulloch EA. Colony assay for prolifirative blast progenitor cells circulating in myeloblastic leukaemia. Lancet (1977) i: 862-863.
3. McCulloch EA. The blast cells of acute myeloblastic leukaemia. Clinics in Hematology. (1984) 13: 503-515.
4. Griffin JD, Löwenberg B. Clonogenic cells in acute myeloblastic leukemia. Blood (1986) 68: 185.
5. Buick RN, Minden MD, McCulloch EA. Self-renewal in culture of leukemic blast progenitor cells in acute myeloblastic leukemia. Blood (1979) 54: 95-104.
6. Löwenberg B, Barman JGJ. Further results in understanding the subpopulation structure of AML: clonogenic cells and their progeny identified by differentiation markers. Blood (1985) 66: 1225-1232.
7. Reilly AG, Kozlowski R, Russell NH. Heterogeneous mechanisms of autocrine growth of AML blasts. Br J Haematol (1989) 72: 363.
8. Löwenberg B, Putten WLJ, van Tow IP, Delwell R, Santini V. Autonomous proliferation of leukemic cells in vitro as a determinant of prognosis in adult acute myeloid leukemia. N Engl J Med (1993) 328: 614.
9. Del Cañizo MC, Almeida J, San Miguel JF, Orfao A, Gonzalez M, Lopez Borrasca A. The phenotype of L-CFU and its correlation with the immunological characteristics of the blast cell population in AML. Ann Hematol (1994) 68: 233-236.
10. Robak T, Dowding C, Garewal G, Hibbin JA, Th'ng KH, Goldman JM. Antigenic determinants on myeloid leukaemia colony-forming cells ressemble those of normal myeloid progenitor cells and differ from those of circulating blast cells. Br J Haematol (1986) 64: 33-148.
11. Kabral A, Bradstock K, grimsley P, Favaloro EJ. Immunophenotype of clonogenic cells in myeloid lukemia. Leuk Res (1988) 12: 51-59.
12. Koeffler HP. Induction of differentiation of human acute myelogenous leukemia cells: therapeutic implications. Blood (1983) 62: 709-721.
13. Macedo A, Orfao A, Vidriales MB, Lopez-Berges MC, Valverde B, Gonzalez M, Caballero MD, Ramos F, Martinez A, San Miguel JF. Immunological detection of blast cell subpopulations in acute myeloblastic leukemia at diagnosis: implications for minimal residual disease studies. Leukemia (1995) 9: 993-1000.
14. Buring HJ, Asenbauer B, Katrilaka K, Hummel G, Busch FW. Sequential expression of CD34 and CD33 antigens on myeloid colony forming cells. European J of Haematology, (1989) 42: 143.
15. Galende J, Cañizo MC, Mota A, Hernandez MD, Almeida J, Vidriales B, Lopez-Macedo A. Action of G-CSF and IL-3 on blast-subpopulations from acute-myeloid leukemia. XXV Congress of the International Society of Hematology, Cancun Mexico, Abril 1994.
16. del Cañizo MC, Galende J, Mota A, Orfao A, Martinez A, Almeida J, San Miguel JF. In leukemic hematopoiesis CD34 antigen does not have the same significance as it does normal hematopoiesis. Leukemia Res (1997) 21: 651-656.
17. Tepstra W, Prins A, Ploemacher RE, Wogum BW, Wagemaker G, Löwenberg B, Wielenga JJ, Long-term leukemic-initiating capacity of a CD34-subpopulation of acute myeloid leukemia. Blood (1996) 87: 2187-93.
18. Osawa M, Hanada K, hamada H, Nakauchi H. Long-term lymphohematopoietic reconstitution by a single CD34-low/ negative hematopoietic stem cell. Science (1996) 273: 242-245.
19. Marie JD, Zittoun R, Thevenin D, Mathier H, Vi ghe F. In vitor culture of clonogenic leukaemia cells in acute myeloid leukaemia: growth pattern and drug sensitivity. Brit J Haematol (1983) 55: 427-437.
20. Aul C, Gatterman N, Schneider W. Comparison of in vitro growth characteristics of blast cells progenitors (CFU-L) in patients with myelodysplastic syndromes and acute myeloid leukemia. Blood (1992) 80: 625-633.
21. Lowenberg B, Tow P. Hematopoietic growth factors and their receptors in acute leukemia. Blood (1993) 81: 281-292.
22. Almeida J, del Cañizo MC, Orfao A, Hernandez J, Hernandez D, Galende J, Caballero D, Garcia Sanz R, San Miguel JF. In vitro autonomous proliferation in AML: clinical and biological significance. Leukemia Res. (1995) 19:411-416.
23. Del Cañizo MC, Brufau A, Almeida J, Galende J, Garcia Marcos M A, Mota A, Garcia R, Fernandez calvo J, Ramos F, Fisac P, Orfao A, San Miguel JF. In vitro growth in acute myeloblastic leukaemia: relationship with other clinico-biological characteristics of the disease. Brit j Haematol (1998) 103: 137-142.
24. Brons PPT, Haanene C, Boezeman JBM, Muus P, Holdrinet RSG, Pennings AHM, Wessels HMC, de Witte T. Proliferation patterns in acute myeloid leukemia: leukemic clonogenic growth and in vivo cell cycle kinetics. Annals Hematol (1993) 66: 225-233.
25. Harikoshi A, Sawada S, Endo M, Kawanura M, Murakami J, Izuka Y, Takenchi J, Oshima T, Horie T, Motoyoshi K. Relationship between responsiveness to colony stimulating factors (CSFs) and surface phenotype of leukemic blasts. Leukemia Res. (1995) 19: 95-201.
26. Kuss BJ, Deeley RG, Cole SP, Willman CL, Kopecky KJ, Wolman SR, Eyre HJ, Lane SA, Nancarrow JK, Whitmore SA. Deletion of gene drug resistance in acute myeloid leukaemia with inversion in chromosome 16: prognostic implications. Lancet (1994) 343: 1531-1534.
27. Moore MAS, Spitzer G, Williams G, Metcalf D, Buckley J. Agar culture studies in 127 cases of untreated acute leukaemia: the prognostic value of reclassification of leukaemia according to in vitro growth characteristics. Blood (1974) 44: 1-18.
28. Browman G, Goldberg J, Gottlieb AJ, Preisler HD, Azarnia N, Priore RL, Brennan JK, Vogler WR, Winton EF, Miller KB, Grunwald H. The clonogenic assay as reproductible in vitro system to study predictive parameters of treatment outcome in acute non lymphoblastic leukaemia. Am J Hematol. (1983) 15: 227-232.
29. Mertelsmann R, Moore MAS, Broxmeyer HE. Diagnostic and prognostic significance of the CFU-C assay in acute non lymphoblastic leukaemia. Cancer Res (1981) 41: 4844-4848.
30. Oster W, Cicco NA, Klein H, Hirano T, Kishimoto T, Lindemann A, Mertelsmann RH, Herrmann F. Participation ofthe cytokines interleukin 6, tumor necrosis factor alpha and nterleukin-1 beta secreted by acute myelogenous leukemia blasts in autocrine and paracrine leukemia growth control. J Clin Invest (1989) 84: 451-459.
31. Metz T, Graf T, Leutz A. Activation of cMGF expression is a critical step in avian myeloid leukemogenesis. EMBO (1991) 10: 837-840.
32. Miller CB, Zenhbauer BA, Piantadosi S, Rowley SD, Jones RJ. Correlation of occult clonogenic leukemia drug sensitivicy with relapse after autologous bone marrow transplalation. Blood (1991) 78: 1126-1136.
33. Gerhartz HH, Schmetzer H. Detection of minimal residual disease in acute myeloid leukemia. Leukemia (1990) 4: 508-516.
34. Aul C, Gatterman N, Schneider W. Comparison of the in vitro growth characteristics of blast cell progenitors (CFU-L) in patients with myelodysplastic syndromes and acute myeloid leukemia Blood (1992) 80: 625-633.
35. del Cañizo MC, Mota A Orfao A, Galende J, CAballero MD, Garcia Marcos MA, San Miguel JF. Value of CFU-GM assay in predicting relapse in acute myeloid leukemia. J. Clin. Pathol. (1996) 49: 450-452.